Почетна › Srpastoćelijska bolest › Ilinois
Kliničke studije za Srpastoćelijska bolest u državi Ilinois
19 studija za Srpastoćelijska bolest traži učesnike na lokacijama u državi Ilinois.
Gradovi u državi Ilinois
Zvanični tekst studije (na engleskom)
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- University of Illinois Hospital and Health Sciences System, Chicago
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07187973A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Uni of Illinois Hospital and HSC, Chicago
Тражи се учесникФаза 3
Узраст од 12 до 100 · Оба пола · Ажурирано 10. 11. 2026. · NCT06439082The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- University of Illinois-Chicago - College of Medicine- Site Number : 8400054, Chicago
Тражи се учесникФаза 3
Узраст од 10 до 65 · Оба пола · Ажурирано 15. 10. 2026. · NCT06975865Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
Тражи се учесник
Узраст од 16 до 39 · Оба пола · Ажурирано 8. 10. 2026. · NCT06374238Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- University of Illinois at Chicago, Chicago
Тражи се учесникФаза 2
Узраст 12 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT06699849A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
- University of Illinois at Chicago College of Medicine, Chicago
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT04055818A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Univer Of Illinois at Chicago, Chicago
Тражи се учесникФаза 3
Узраст 2 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT06609226A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Childrens Hospital of Chicago, Chicago
- Univer Of Illinois at Chicago, Chicago
Тражи се учесникФаза 3
Узраст 12 и старији · Оба пола · Ажурирано 17. 9. 2026. · NCT06612268Tocilizumab for Acute Chest Syndrome
- University of Chicago, Chicago
Тражи се учесникФаза 2
Узраст 12 и старији · Оба пола · Ажурирано 15. 9. 2026. · NCT05640271A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- University of Illinois at Chicago Clinical Research Center, Chicago
- University of Illinois Hospital and Health Sciences System - Investigational Drug Services (IDS), Chicago
- University of Illinois Hospital and Health Sciences System, Chicago
Тражи се учесникФаза 2/3
Узраст 12 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT05431088A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Local Institution - 0034, Chicago
Тражи се учесникФаза 1/2Здраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT06481306ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Rush University Medical Center, Chicago
- Bleeding and Clotting Disorders Institute, Peoria
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 17. 8. 2026. · NCT04398628Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
- University of Illinois at Chicago, Chicago
Тражи се учесникФаза 2
Узраст од 16 до 60 · Оба пола · Ажурирано 8. 7. 2026. · NCT03121001Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Comer Children's Hospital (MRD-HCT), Chicago
Тражи се учесникОпсервациона студија
Узраст од 3 до 20 · Оба пола · Ажурирано 4. 6. 2026. · NCT06941389Sickle Cell Clinical Research and Intervention Program
- Children's Hospital of Illinois at OSF-Saint Francis Medical Center, Peoria
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 4. 6. 2026. · NCT02098863Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
- University of Illinois Chicago, Sickle Cell Center, Chicago
Тражи се учесникФаза 2
Узраст од 18 до 60 · Оба пола · Ажурирано 19. 5. 2026. · NCT07175051Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
- University of Illinois at Chicago, Chicago
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 23. 3. 2026. · NCT06919224Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Тражи се учесникФаза 2
Узраст од 2 до 25 · Оба пола · Ажурирано 10. 3. 2026. · NCT03587272Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
- University of Illinois, Chicago
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 22. 6. 2025. · NCT06385886Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.